Successful Treatment of Interferon Alfa-Induced Mood Disorder With Nortriptyline

1994 ◽  
Vol 35 (4) ◽  
pp. 412-413 ◽  
Author(s):  
Larry S. Goldman
Keyword(s):  
Mood Disorder ◽  
Successful Treatment ◽  
Interferon Alfa ◽  
Induced Mood

Successful Treatment of Interferon-α-Induced Mood Disorder With Nortriptyline

1995 ◽  
Vol 36 (4) ◽  
pp. 418-419 ◽  
Author(s):  
Alan D. Valentine ◽  
Christina A. Meyers
Keyword(s):  
Mood Disorder ◽  
Successful Treatment ◽  
Interferon Α ◽  
Induced Mood

Tramadol-associated mania: A case report

2017 ◽  
Vol 13 (3) ◽  
pp. 197 ◽  
Author(s):  
Jamaluddin Nimah, MD ◽  
Alexander Chen, BA ◽  
Kelly N. Gable, PharmD, BCPP ◽  
Alan R. Felthous, MD
Keyword(s):  
Oxidative Stress ◽  
Bipolar Disorder ◽  
Case Report ◽  
Mood Disorder ◽  
Tricyclic Antidepressants ◽  
Unusual Case ◽  
Underlying Mechanism ◽  
Induced Mood ◽  
History Of

A variety of medications, most notably tricyclic antidepressants, and other antidepressants including venlafaxine have been reported to have triggered manic episodes in patients with bipolar disorder. The synthetic opioid tramadol has also been associated with mania activation. This report describes an unusual case of tramadol-associated mania in a patient without a charted diagnosis of bipolar disorder. However, she had a history of two prior episodes of mania following administration of tramadol that were also believed to be related to medication-induced mood disorder rather than underlying bipolar disorder. We hypothesize that tramadol-associated mania may have an underlying mechanism involving monoamine neurotransmission and increased oxidative stress.

Management of psychiatric adverse events with immunotherapy with interferon-alfa

1999 ◽  
Vol 11 (4) ◽  
pp. 120-124 ◽  
Author(s):  
A.R. Van Gool ◽  
W.H.J. Kruit ◽  
J.J. Cornelissen ◽  
L. Berk ◽  
A.M.M. Eggermont ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Side Effects ◽  
Patient Education ◽  
Standard Therapy ◽  
Interferon Alfa ◽  
Myelogenous Leukemia ◽  
Close Collaboration ◽  
Induced Mood ◽  
Adequate Management ◽  
Neuropsychiatric Side Effects

SummaryImmunotherapy with interferon-alfa has become standard therapy in selected patients with viral hepatitis and chronic myelogenous leukemia. In addition, it is used in a variety of other diseases, both as standard therapy and in clinical trials. Its use is expected to expand in the following decade. Interferon can cause (severe) neuropsychiatric side effects. These side effects are discussed. Adequate management of these side effects is important, as is close collaboration between the oncologist and the psychiatrist. The cornerstone of management is patient education: this prevents interruption of therapy by patients who were not warned for neuropsychiatric side effects. Furthermore, patients should report in case of rapidly arising mood disorders. Interferon-alfa induced mood disorder is reported to be treatable. Three case descriptions illustrate this, but also illustrate some limits to successful treatment.

Successful Treatment of Corneal and Conjunctival Intraepithelial Neoplasia with Topical Interferon Alfa-2b: Case Report

2015 ◽  
Vol 24 (1) ◽  
pp. 46-49
Author(s):  
Emine KALKAN AKÇAY ◽  
Necati DURU ◽  
Gamze DERELİ CAN ◽  
Aydan KILIÇARSLAN ◽  
Muhammed Bülent AKINCI ◽  
...  
Keyword(s):  
Case Report ◽  
Successful Treatment ◽  
Intraepithelial Neoplasia ◽  
Interferon Alfa ◽  
Conjunctival Intraepithelial Neoplasia

Successful treatment of generalized lichen planus with recombinant interferon alfa-2b

1995 ◽  
Vol 33 (5) ◽  
pp. 880-883 ◽  
Author(s):  
Axel Hildebrand ◽  
Gerhard Kolde ◽  
Thomas A Luger ◽  
Thomas Schwarz
Keyword(s):  
Lichen Planus ◽  
Successful Treatment ◽  
Interferon Alfa ◽  
Recombinant Interferon

scholarly journals A case of methamphetamine use disorder presenting a condition of ultra-rapid cycler bipolar disorder

2019 ◽  
Vol 7 ◽  
pp. 2050313X1982773
Author(s):  
Haruki Ikawa ◽  
Sho Kanata ◽  
Akihisa Akahane ◽  
Mamoru Tochigi ◽  
Naoki Hayashi ◽  
...  
Keyword(s):  
Bipolar Disorder ◽  
Mood Disorder ◽  
Depressive Mood ◽  
Mood Stabilizers ◽  
Psychotic Symptoms ◽  
High Dose ◽  
Distinctive Features ◽  
Methamphetamine Use ◽  
Induced Mood ◽  
Methamphetamine Use Disorder

Methamphetamine, a potent psychostimulant, may cause a condition of mood disorder among users. However, arguments concerning methamphetamine-induced mood disorder remain insufficient. This case study describes a male with methamphetamine-induced bipolar disorder not accompanied by psychotic symptoms, who twice in an 11-year treatment period, manifested an ultra-rapid cycler condition alternating between manic and depressive mood states with 3- to 7-day durations for each. The conditions ensued after a bout of high-dose methamphetamine use and shifted to a moderately depressive condition within 1 month after the use under a treatment regimen of aripiprazole and mood stabilizers. The cycler condition may be characteristic of a type of the bipolar disorder and a sign usable for characterization. Further efforts are needed to seek distinctive features and to improve diagnostic assessment of methamphetamine-induced mood disorders.

Sign in / Sign up

Export Citation Format

Share Document